Literature DB >> 13042677

Carcinoma of the prostate; diagnosis and treatment.

J C PRESTI.   

Abstract

About 28 per cent of men between the ages of 71 and 75 have cancer of the prostate. Many of them do not die of the disease, but with the life span ever increasing, this problem is becoming more important. In the early stages the condition is asymptomatic; when the symptoms of urinary obstruction arise, the cancer is usually too advanced for cure. Cure depends on early diagnosis and, therefore, on routine rectal examination. The solitary hard nodule of early prostatic cancer becomes a stony hard fixed prostate as the condition progresses. X-ray and acid phosphatase studies are of help only after the cancer has metastasized. As many as 50 per cent of patients with rectally palpable early carcinoma of the prostate can be cured by radical perineal prostatectomy. Often, simple enucleation or transurethral resection is sufficient to effect cure in the case of occult carcinoma. However, some observers believe that when cancer is detected by microscopic examination of a prostate that has been removed, a radical operation should be done as soon after the initial operation as feasible. Early orchidectomy and estrogen therapy are of considerable help in slowing the process of advanced prostatic cancer and may postpone the need of transurethral resection to relieve obstruction. When these measures fail, bilateral adrenalectomy, cortisone therapy, pituitary irradiation, and pituitary extirpation have been employed, with moderate success, in an effort to diminish the androgen level.

Entities:  

Keywords:  PROSTATE/neoplasms

Mesh:

Year:  1953        PMID: 13042677      PMCID: PMC1521719     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  9 in total

1.  Bilateral Adrenalectomy in Prostatic Cancer: Clinical Features and Urinary Excretion of 17-Ketosteroids and Estrogen.

Authors:  C Huggins; W W Scott
Journal:  Ann Surg       Date:  1945-12       Impact factor: 12.969

2.  Surgery of the adrenals.

Authors:  C HUGGINS; D M BERGENSTAL
Journal:  J Am Med Assoc       Date:  1951-09-08

3.  Pituitary irradiation in prostatic carcinoma.

Authors:  W T MURPHY; H SCHWIPPERT
Journal:  Radiology       Date:  1951-03       Impact factor: 11.105

4.  Management of occult prostatic carcinoma.

Authors:  R M NESBIT; W C BAUM
Journal:  J Urol       Date:  1951-05       Impact factor: 7.450

5.  The prostatic smear; cell changes after estrogen therapy.

Authors:  H PETERS; J A BENJAMIN
Journal:  Surg Gynecol Obstet       Date:  1950-12

6.  Radical treatment of carcinoma of the prostate gland by cystovesiculoprostatectomy.

Authors:  A WESTERBORN
Journal:  Surg Gynecol Obstet       Date:  1950-12

7.  Occult prostatic carcinoma diagnosed upon transurethral resection.

Authors:  F HINMAN; F HINMAN
Journal:  J Urol       Date:  1949-11       Impact factor: 7.450

8.  Endocrine control of prostatic carcinoma; clinical and statistical survey of 1,818 cases.

Authors:  R M NESBIT; W C BAUM
Journal:  J Am Med Assoc       Date:  1950-08-12

9.  Preliminary report on the clinical use of tace (chlorotrianisene) in treatment of prostatic carcinoma.

Authors:  P G SMITH; T W RUSH; A T EVANS
Journal:  J Urol       Date:  1951-05       Impact factor: 7.450

  9 in total
  1 in total

1.  Prostatic carcinoma involving the rectum; the problem of differentiation from other malignant lesions.

Authors:  C C WINTER
Journal:  Calif Med       Date:  1955-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.